What 4 Analyst Ratings Have To Say About West Pharmaceutical Servs
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have published their opinions on West Pharmaceutical Servs (NYSE:WST) stock, with one being bullish and three somewhat bullish. The average price target is $406.25, implying an upside from the current price of $393.025. The average price target has increased by 4.84% over the past month.
August 21, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are generally bullish on West Pharmaceutical Servs (NYSE:WST), with an average price target of $406.25, indicating potential upside.
The bullish sentiment from analysts, along with the average price target that is higher than the current price, suggests potential upside for the stock. This could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100